The African Critical Illness Outcomes Study
Launched by UNIVERSITY OF CAPE TOWN · Sep 20, 2023
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
STUDY OBJECTIVES
The objectives of this study are to determine:
1. The proportion of hospital patients who are critically ill,
2. The mortality associated with critical illness,
3. The proportion of critically ill patients who receive essential emergency and critical care,
4. The relationship between essential emergency and critical care provision, and mortality, and
5. The availability of resources necessary to provide essential emergency and critical care.
STUDY DESIGN
An African multi-centre prospective observational cohort study of adult (≥18 years) in-hospital patients. Patient fol...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients aged 18 years or over who have been admitted for inpatient care in any department or ward in participating hospitals.
- Exclusion Criteria:
- • None
About University Of Cape Town
The University of Cape Town (UCT) is a leading research institution in South Africa, renowned for its commitment to advancing medical science and improving public health outcomes. With a strong emphasis on innovation and interdisciplinary collaboration, UCT conducts a wide range of clinical trials aimed at addressing critical health challenges both locally and globally. The university's dedicated research teams leverage cutting-edge methodologies and ethical standards to ensure the integrity and efficacy of their studies, fostering an environment that promotes scientific excellence and enhances the understanding of various medical conditions. Through its robust partnerships with healthcare institutions and community organizations, UCT is poised to make significant contributions to the field of clinical research and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Khartoum, , Sudan
Patients applied
Trial Officials
Tim Baker, MBChB; PhD
Principal Investigator
Muhimbili University of Health and Allied Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported